Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Vedolizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Vedolizumab (rch) [PDF, 961.6 KB]

AusPAR: Vedolizumab (rch) [Word, 966.03 KB]

Attachment: Product Information: Vedolizumab (rch) [PDF, 202.62 KB]

Attachment: Product Information: Vedolizumab (rch) [Word, 77.81 KB]

Attachment: Extract from the Clinical Evaluation Report: Vedolizumab (rch) [PDF, 905.18 KB]

Attachment: Extract from the Clinical Evaluation Report: Vedolizumab (rch) [Word, 1.03 MB]

Device/Product Name

Entyvio / Kynteles

Active ingredients

Vedolizumab (rch)

AusPAR Date

17 November 2014

Published

11 December 2014

Submission Number

PM-2013-01102-1-1

Submission Type

New biological entity

Decision

Approved